If carried out according to plan, the Whitecap project would develop 240 acres of land and be Corpus Christi's first ...

Increase in sales of ProSense®, based on preliminary unaudited results, demonstrate growing adoption of ProSense® cryoablation for breast tumors.FDA decision on market authorization of ProSense® for ...

Thai police have successfully extradited "Sergeant M," age 41, from Cambodia just five days after the fatal shooting of a former Cambodian MP in Bangkok's historic district.

It was more recently presented by current Whitecap Dakota Chief Darcy Bear to bolster the case that Lakota/Dakota people have never been properly compensated or recognized for their wartime ...

Bausch + Lomb (BLCO) announced an affiliate has acquired Whitecap Biosciences which is currently developing two innovative therapies for potential use in glaucoma and geographic atrophy GA ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an affiliate has acquired Whitecap ...

Customers urged to have a plan and make preparations for potential freezing temperatures and wintry precipitation ...

VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an affiliate has acquired ...

The acquisition, detailed today, brings Whitecap Biosciences' investigational drugs, including WB007, into Bausch + Lomb's portfolio. WB007, a potent alpha-2 adrenergic agonist, has successfully ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The USDA’s Food Safety and Inspection Service (FSIS) has published its report on inspection practices used by the agency in relation to the deadly 2024 Listeria outbreak traced to Boar’s Head ...

III study in treating thyroid eye disease. The privately held company posted top-line efficacy and safety results from a phase IIb/III study of its lead candidate, linsitinib, which hits its primary ...